Global IntravenousSolution Market, By Solution (Saline (Normal Saline (0.9% NaCl) andHypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins &Minerals, Heparin and Trace Elements, and Mixed Solutions), By Bag Type (LargeVolume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), ByApplication (Basic IV Solution, Nutritional IV Solution, Blood IV Solution,Drug IV Solution, and Irrigation IV Solution), By End-user (Hospitals, Clinics,Ambulatory Surgery Centers, and Home Care Settings), and By Region (NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa) wasvalued at US$ 8,372.0 million in 2019,and is expected to exhibit a CAGR of 6.1% over the forecast period (2019 -2027), as highlighted in a new report published by.
Increasing cases of kidneyfailures are expected to lead to high adoption of dialysis procedures, which isexpected to drive the market growth over the forecast period. Kidney failure isa condition in which the kidney loses its functioning ability of removing wasteand extra fluids from the body. Dialysis procedure is recommended for suchconditions. For instance, according to the National Kidney FoundationFactsheet, in March 2015, an estimated 10% of the global population wasaffected by chronic kidney disease (CKD), and around 2 million people receivedtreatment for kidney failure. Moreover, according to the National Institute ofHealth (NIH), in December 2016, an estimated 661,000 people in the U.S.suffered from kidney failure. Among these, around 468,000 patients were ondialysis, and around 193,000 underwent kidney transplant procedures. Accordingto the same source, around 88.2% of end-stage renal disease (ESRD) patients inthe U.S. underwent renal replacement therapy with hemodialysis. 9.0% of thesepatients received peritoneal dialysis, and 2.6% had received kidney transplantin 2013.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1134
Browse 34 Market Data Tables and35 Figures spread through 215 Pages and in-depth TOC on "IntravenousSolution Market, By Solution (Saline (Normal Saline (0.9% NaCl) and HypertonicSaline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals,Heparin and Trace Elements, and Mixed Solutions), By Bag Type (Large VolumeBags (greater than 250ml) and Small Volume Bags (less than 250ml)), ByApplication (Basic IV Solution, Nutritional IV Solution, Blood IV Solution,Drug IV Solution, and Irrigation IV Solution), By End-user (Hospitals, Clinics,Ambulatory Surgery Centers and, Home Care Settings), and By Region (NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa) - GlobalForecast to 2027"
Major market players are focusedon development of products, which enhances patient safety and prevents IVmedication administration errors in order to avoid patient injury and loweringpain. For instance, in March 2017, Becton, Dickinson and Company launched an IVMedication Safety Solution, at the European Association of Hospital Pharmacists(EAHP) congress, in France. This product was developed for prevention of IVmedication administration errors.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/intravenous-solutions-market-1134
Key Takeaways of the IntravenousSolution Market:
The global intravenous solutionmarket is expected to expand at a CAGR of 6.1% over the forecast period(2019–2027), owing to increasing cases of kidney failure and dialysis
Among solution type, the salinesolution segment is expected to account for major revenue share in 2027, owingto increasing incidence of gastroenteritis globally. For instance, according tothe Global Burden of Disease Study, in 2015, there were two billion cases ofgastroenteritis, resulting in 1.3 million deaths globally.
Major players operating in theglobal intravenous solution market include Baxter International Inc, ICUMedical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC,Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, AxaParenterals Ltd, and Salius Pharma Private Limited
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1134
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
